Congratulations - It's a Dog! The Maker of NexGard® (afoxolaner) Launches Online Registry for Dogs

DULUTH, Ga., April 19, 2017 /PRNewswire/ -- From chew toys to crates and collars to cleaning supplies, preparing for a new dog requires planning and preparation. Today, Merial, now part of Boehringer Ingelheim, announced the launch of the NexGard^® (afoxolaner) It's a Dog! online pet registry to celebrate the joyous act of adding a dog to a household. The NexGard team wants to help welcome new dogs – be they puppies, seniors, or any age in-between – into their new homes and make the transition a little easier.

From April to October, dog owners can create a pet profile and customize a registry on ItsADog.com to be entered for a chance to win one of two prizes. One Grand Prize winner each month will receive $500 towards their registry and a coupon for a six-month supply of NexGard, while two Runners Up will receive $100 towards their pet registry and a coupon for a three-month supply of NexGard. Twenty-one lucky dog owners will win! NexGard is a prescription drug and is available at veterinarian offices nationwide.

New pet owners can also find expert tips and information on how to help keep their dogs healthy, how to minimize housebreaking accidents and how to help protect their dogs from fleas and ticks on ItsADog.com.

"With a new pet in the family, there are plenty of first-time decisions to make – even for the experienced dog owner," said Mike Hutton, executive director of U.S. pets marketing for Merial. "The goal of the registry is to connect dog owners with products that make providing care for their dogs easy, like NexGard."

NexGard is the number one veterinarian-recommended flea and tick control product¹, and is safe for use in puppies as young as eight weeks weighing four pounds or more. NexGard is a soft, beef-flavored chew that kills both fleas and ticks for a full 30 days – and dogs love it²!

IMPORTANT SAFETY INFORMATION
The most frequently reported adverse reactions include vomiting, itching, diarrhea, lethargy and lack of appetite. The safe use of NexGard in pregnant, breeding or lactating dogs has not been evaluated. Use with caution in dogs with a history of seizures. For more information, contact your veterinarian or see the prescribing information. 

About Boehringer Ingelheim Animal Health
On January 1, 2017, Merial became part of the Boehringer Ingelheim group. As the second largest animal health business in the world, Boehringer Ingelheim is committed to making the industry even better at improving animal health. With more than 10,000 employees worldwide, Boehringer Ingelheim Animal Health has products available in more than 150 markets and a global presence in 99 countries. For more information about Boehringer Ingelheim Animal Health, click here.

About Boehringer Ingelheim
Boehringer Ingelheim is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates presently with a total of some 50,000 employees worldwide. The focus of the family-owned company, founded in 1885, is on researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine. In 2015, Boehringer Ingelheim achieved net sales of about 14.8 billion euros. R&D expenditure corresponds to 20.3 percent of net sales. For more information, please visit www.boehringer-ingelheim.com

References

     1      Data on file at Merial.
     2      Data on file at Merial.

®NexGard is a registered trademark of Merial.
©2017 Merial, Inc., Duluth, GA. All rights reserved. Merial is now part of Boehringer Ingelheim.
[NG17_IAD_PressRelease] (4/17)

SOURCE Merial